Personalizing Hemophilia Care Through Shared Decision-Making – EAHAD
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn about a recent article by Quentin Van Thillo et al, published in Haemophilia, adding:
“With an increasing number of innovative treatment options available, choosing the most appropriate therapy requires careful consideration of individual patient needs and preferences.
Check out the recently published article on Haemophilia Journal exploring 15 key treatment differentiators to support clinicians in shared decision-making discussions, complementing the existing World Federation of Hemophilia.”
Title: Shared Decision-Making in Haemophilia Involves More Treatment Differentiators in 2026
Authors: Quentin Van Thillo, Guy Young, Cedric Hermans
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 6, 2026, 10:29Luisa Weiss: How Platelets Drive Inflammation in Aortic Valve Disease
-
Nov 6, 2026, 10:18Dave Cartland: A Rare Case of Portal Vein Thrombosis After Moderna Vaccination
-
Nov 6, 2026, 10:10Iván Camilo Triana Avellaneda: Uncovering Distinct Clinical Phenotypes of DVT
-
Nov 6, 2026, 10:06Rafael Zubirán: Lp(a) – The Missing Link Between Inflammation and Thrombosis
-
Nov 6, 2026, 09:59Syeda Jazilah Faisal: Upstream Heparin in STEMI – Improving Coronary Reperfusion Before PCI
-
Nov 6, 2026, 09:51N. Mariana S. Vasquez: Understanding the 3 Main Types of Leg Ulcers
-
Nov 6, 2026, 08:22How Bleeding Disorders Affect Social Life and Well-Being? – EHC
-
Nov 6, 2026, 08:13Jared Rice: Why Neonatal Coagulation Cannot Be Interpreted Like Adult Coagulation
-
Nov 6, 2026, 08:07Matthew Smeds: Endovascular Salvage of Acute IVC Thrombosis After Liver Transplantation